Anti-TNF-Alpha-Adalimumab Therapy Is Associated with Persistent Improvement of Endothelial Function without Progression of Carotid Intima-Media Wall Thickness in Patients with Rheumatoid Arthritis Refractory to Conventional Therapy

• Main Authors: Carlos Gonzalez-Juanatey (Author), Tomas R. Vazquez-Rodriguez (Author), Jose A. Miranda-Filloy (Author), Ines Gomez-Acebo (Author), Ana Testa (Author), Carlos Garcia-Porrua (Author), Amalia Sanchez-Andrade (Author), Javier Llorca (Author), Miguel A. González-Gay (Author)
• Format: Book
• Published: Hindawi Limited, 2012-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

To determine whether treatment with the anti-TNF-alpha blocker adalimumab yields persistent improvement of endothelial function and prevents from morphological progression of subclinical atherosclerosis in patients with rheumatoid arthritis (RA) refractory to conventional therapy, a series of 34 con...